Understanding the nuanced perspectives of both patients and healthcare professionals (HCPs) is crucial for developing effective and empathetic communication strategies. A recent case study demonstrates how Drug-GPT’s Audience Analyzer enabled a healthcare advertising agency to achieve just that.
The agency faced significant challenges in uncovering fresh insights about type II inflammation from both patients and HCPs, and in tailoring their messaging to effectively resonate with these diverse audiences. The goal was to bridge the communication gap and enhance engagement with Brand X.
The primary objective was to harness data from HCPs and patients to uncover novel insights and compare the terminology used by both groups concerning type II inflammation. This data-driven approach aimed to inform the development of a targeted campaign for Brand X. By utilising Drug-GPT, the agency accessed a wealth of data from closed communities, client market research, and open-source social data. This comprehensive data vault allowed for natural language queries, enabling the agency to derive actionable intelligence and effectively inform their creative strategy.
The use of Drug-GPT’s Audience Analyzer revealed key differences in language and awareness between patients and HCPs. For example, while HCPs commonly used technical terms like “type II inflammation,” patients referred to their experiences with terms like “flare-ups,” “steroids,” “severe wheeziness,” and “consultant visits.” This understanding enabled the agency to develop a more patient-centric campaign, ensuring that the messaging resonated more deeply with the target audience.
The result was a campaign that effectively bridged the communication gap, enhancing the impact and relevance of Brand X’s messaging. By tailoring their approach based on AI-driven insights, the agency was able to connect more authentically with both patients and HCPs.
This case study underscores the importance of leveraging advanced data science and AI tools like Drug-GPT to inform creative strategies in healthcare marketing. By tapping into comprehensive data and uncovering nuanced insights, agencies can develop more empathetic and effective communication strategies that resonate with their audience. Drug-GPT’s Audience Analyzer proved to be an invaluable asset in this process, demonstrating the power of AI in transforming healthcare advertising.
Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams. The Talking Medicines mission is to be the World’s Gold Standard for Patient Intelligence by Medicine.
